Radioiodine ablation of post-surgical thyroid remnants after preparation with recombinant human TSH: Why, how and when
- 30 June 2007
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 33 (5) , 535-540
- https://doi.org/10.1016/j.ejso.2007.01.017
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Clinical uses of recombinant human thyrotropinExpert Opinion on Pharmacotherapy, 2004
- A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2004
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2001
- Pharmacology of Bovine and Human Thyrotropin: An Historical PerspectiveThyroid®, 1999
- Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 1998
- Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone TherapyThyroid®, 1997
- Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid CarcinomaThyroid®, 1997
- Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)Journal of Clinical Endocrinology & Metabolism, 1994
- Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkeyJournal of Clinical Endocrinology & Metabolism, 1992
- Biological Activity and Metabolic Clearance of a Recombinant Human Thyrotropin Produced in Chinese Hamster Ovary CellsEndocrinology, 1991